| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.8B | $38.5B | $36.7B | $35.5B | $34.4B | $9.5B | $9.7B | $10.8B |
| Cost of Revenue | $23.6B | $23.8B | $23.0B | $23.8B | $23.4B | $24.3B | $29.0B | $27.6B |
| Gross Profit | $3.5B | — | — | — | $2.9B | $3.2B | $3.0B | $3.3B |
| R&D Expense | $1.8B | $1.5B | $1.5B | $1.5B | $1.3B | $1.6B | $1.8B | $1.8B |
| SG&A Expense | $5.5B | $5.5B | $5.1B | $5.2B | $4.8B | $5.5B | $6.1B | $5.8B |
| Operating Income | $8.1B | $8.7B | — | — | — | — | — | — |
| Net Income | $-0.1B | $5.7B | $5.7B | $5.0B | $5.5B | $1.6B | $1.7B | $-2.4B |
| EPS (Basic) | $-0.18 | $8.76 | $8.53 | $7.33 | $8.01 | $2.19 | $2.34 | $-3.18 |
| EPS (Diluted) | $-0.18 | $8.71 | $8.47 | $7.27 | $7.91 | $2.16 | $2.31 | $-3.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $73.7B | $75.2B | $61.5B | $62.3B | $64.5B | $58.7B | $57.8B | $59.4B |
| Current Assets | $30.4B | $27.9B | $23.5B | $25.0B | $25.4B | $24.3B | $24.4B | $26.0B |
| Cash & Equivalents | $12.5B | $10.6B | $7.9B | $9.6B | $11.0B | $9.1B | $9.3B | $7.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $23.4B | $21.3B | $18.5B | $19.9B | $19.5B | $18.1B | $18.9B | $18.9B |
| Stockholders' Equity | $13.9B | $18.6B | $15.9B | $16.7B | $18.6B | $18.5B | $18.2B | $17.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.4B | $6.1B | $5.3B | $5.3B | $6.0B | $6.9B | $6.4B | $6.0B |
| Investing Cash Flow | $-2.7B | $-10.2B | $-1.3B | $-0.1B | $-1.1B | $-0.5B | $1.0B | $-3.6B |
| Capital Expenditures | $1.0B | $1.2B | $1.0B | $0.8B | $0.9B | $0.8B | $0.8B | $1.0B |
| Financing Cash Flow | $-2.0B | $6.8B | $-5.8B | $-6.3B | $-8.3B | $-6.6B | $-5.0B | $-3.5B |